36 results
8-K
EX-10.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
26 Apr 24
Bio-Rad Announces Life Science Group Management Changes
8:30am
performance targets or criteria with respect thereto); and (iv) the grant or exercise price per share for any outstanding Awards under the Plan.
(b
8-K
EX-99.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
4 May 23
Bio-Rad Reports First-Quarter 2023 Financial Results
4:18pm
financial outlook for full-year 2025 presented at the company’s 2022 Investor Day event on February 25, 2022. The company now targets a currency
8-K
EX-99.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
25 Feb 22
Regulation FD Disclosure
9:19am
net capital expenditures
Exceeded Our Revenue Targets Driving Revenue Growth Expanding EBITDA Margins Accelerating Free Cash Flow Creating Shareholder … -GAAP revenue excludes payments from legal settlements
Exceeded Our EBITDA Margin Targets Realized operating leverage Driving Revenue Growth Expanding
8-K
EX-99.2
6lc7ts3hd ziq
25 Feb 22
Regulation FD Disclosure
9:19am
CORRESP
2v4lrcqs x3c1f
25 Jun 10
Correspondence with SEC
12:00am